Cardiology Search
Cardiology Cardiology
peripheral%20arterial%20disease
PERIPHERAL ARTERIAL DISEASE
Peripheral arterial disease includes a range of vascular syndromes caused by atherosclerosis and thromboembolic pathophysiological processes that alter the normal structure and function of the aorta, its visceral arterial branches and the arteries of the lower extremity.
Individuals at risk for lower extremity peripheral arterial disease should undergo review of vascular symptoms and comprehensive vascular examination to assess walking impairment, claudication, ischemic rest pain and/or the presence of nonhealing wounds.
Patients with peripheral arterial disease may be symptomatic or asymptomatic. Symptoms may range from claudication presenting as exertional leg pain to chronic limb-threatening ischemia presenting as rest pain, ulceration or gangrene.

Peripheral Arterial Disease Drug Information

Drug Information

Indication: Essential HTN.

Indication: Thrombolytic treatment in acute MI, acute massive pulmonary embolism w/ haemodynamic instability & of acut...

Atozet
atorvastatin + ezetimibe

Indication: Reduced risk of CV death, nonfatal MI & stroke, hospitalization for unstable angina or need for revascular...

Indication: Adjunct to diet for patients w/ elevated total cholesterol (total-C) & LDL-cholesterol (LDL-C), apolipopro...

Indication: Thrombolytic treatment of acute MI. Treatment initiated as soon as possible after symptom onset.

Indication: Essential HTN. Reduction of the risk of MI, stroke or death in patients ≥55 yr at high risk developing majo...

Indication: Essential HTN when BP is inadequately controlled by monotherapy w/ telmisartan.

Indication: Prophylaxis of migraine w/ or w/o aura. Symptomatic treatment of vestibular vertigo, due to a diagnosed functi...

Indication: Maintenance therapy for symptoms of cerebrovascular origins, labyrinthine & peripheral-circulatory disorde...

Indication: Primary hypercholesterolemia: Adjunctive therapy to diet for the reduction of elevated total cholesterol (tota...

1  /  9
1  /  9
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Standard of care guidelines improve outcomes in coronary heart disease patients
26 Jun 2020

Achieving standard of care targets, such as reduced levels of low-density lipoprotein cholesterol and glycated haemoglobin, improves outcomes in coronary heart disease patients, a new study has found.
Functional foods help delay ageing process and prevent noncommunicable diseases
Dr. Joseph Delano Fule Robles, 24 Jul 2018

Functional foods benefit the body beyond its nutritional effects, with studies showing that they can improve general state of health and reduce the risk of diseases.

Lower cholesterol targets after stroke may reduce subsequent major vascular events
29 Mar 2020
Targeting a low-density lipoprotein cholesterol level <70 mg/dL following an ischaemic stroke of atherosclerotic origin helps to avoid one in four subsequent major vascular events without increasing the risk of intracranial haemorrhage over about 5 years of follow-up, according to data from the Treat Stroke to Target trial.
Small dense LDL-C predicts severity, calcification in acute ischaemic stroke patients
23 May 2020
Small dense low-density lipoprotein cholesterol (sd-LDL-C) is a strong predictor of stroke severity and intracranial artery calcification (IAC) in patients with acute ischaemic stroke (AIS), a study has shown.